Aduro Biotech Announces First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Aduro Biotech (ADRO) Posts Q1 Loss of $39.97/Share
May 28, 2015 4:32 PM EDTAduro Biotech (NASDAQ: ADRO) reported Q1 EPS of ($39.97), $39.89 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.6 million versus the consensus estimate of $9.24 million.
The company posted a loss of $26.34 per share in the same period last... More
